Search

everythinglearnresearchcommunity

for

Search:↓

The study found that Keratosis Pilaris Atrophicans is a genetic skin condition that starts in childhood, involves inflammation and scarring, and current treatments are only somewhat effective.

Mesenchymal stem cells show potential for skin healing and anti-aging, but more research is needed for safe use, especially regarding stem cells from induced pluripotent sources.

Costunolide may have multiple health benefits, including promoting hair growth and protecting against cancer and diabetes, but more research is needed.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Toxic epidermal necrolysis is a severe skin condition often caused by drugs, with complex treatment and a high risk of death, but survivors usually heal without scars.

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.

Niosomes are promising for skin drug delivery, offering benefits like improved drug penetration and stability.

Minoxidil and finasteride treat hair loss; more research needed for other options.

Acne is a chronic disease linked to various systemic conditions and has significant psychological and social effects.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Certain groups may need vitamin supplements to improve hair health and prevent other health problems.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

Early onset and pustules indicate severe hair follicle inflammation, and while antibiotics help, the condition often worsens after treatment stops.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Baricitinib is effective and safe for treating severe alopecia areata.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

No cure for female pattern hair loss, but various effective treatments exist.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Hidradenitis suppurativa treatment should be tailored to the individual, with quitting smoking being important.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

The 308-nm excimer laser is a promising treatment for vitiligo with varying success and mild side effects.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Apoptosis is crucial for healthy skin and treating skin diseases.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.